Navigation Links
Bionovo Reports Third Quarter 2008 Financial Results
Date:11/3/2008

compensation and benefits 870,435 462,485

Current portion of lease obligation 793,242 706,710

Other current liabilities 467,088 949,200

Total current liabilities 3,115,031 2,716,631

Non-current portion of lease obligation 693,519 526,346

Commitments and contingencies

Shareholders' equity:

Preferred stock, $0.0001 par value;

10,000,000 shares authorized; none issued

and outstanding - -

Common stock, $0.0001 par value,

190,000,000 shares authorized; 76,363,101

and 76,343,101 shares issued and outstanding

as of September 30, 2008 and December 31,

2007, respectively 7,636 7,634

Additional paid-in capital 58,737,205 57,660,045

Accumulated other comprehensive income (53,450) 4,480

Accumulated deficit (35,963,783) (22,749,965)

Total shareholders' equity 22,727,608 34,922,194

Total liabilities and shareholders'

equity $26,536,158 $38,165,171

* The balance sheet at December 31, 2007 has been derived from the audited

financial statements at that date but does not include all of the

information and footnotes required by accounting principles generally

accepted in the United States for complete financial statements.


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 As part of its ... (BDWMC), Sun Health Foundation funded a $3.25 million project ... pharmacy with the most up-to-date features and technology. , ... The pharmacy's 45 staff members will begin moving from ... in the coming days. , The current pharmacy ...
(Date:5/20/2015)... SAN FRANCISCO, Calif. , May 20, 2015 ... VCYT ) today presented preliminary data demonstrating the ... distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial ... The findings suggest the classifier,s potential to help ... surgery to resolve ambiguity in IPF diagnosis – ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 The global ... of 22.3% during the forecast period of 2015 to ... increasingly being used in drug discovery and development process ... market growth. In addition to this,heavy investments by key ... applications are also propelling market growth. Browse 113 market ...
(Date:5/20/2015)... 20, 2015  Cypher Genomics, Inc., a leading ... Celgene Corporation to apply Cypher,s Coral TM ... with patient response to innovative medicines. The information ... accelerate patient access to the right medicine at ... and development and potentially inform new companion diagnostics.  ...
Breaking Biology Technology:Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2
... called Clostridium has a protective coat of armour that ... on its own, which may have important commercial uses ... September 2007) at the Society for General Microbiology,s 161st ... from 3-6 September 2007. , Like many other micro-organisms, ...
... 99% Year-Over-Year, SHANGHAI, China, Sept. 5 ... WX ) ("WuXi PharmaTech" or "the Company"), ... development,outsourcing company, today announced its unaudited financial ... 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), ...
... Alba Therapeutics Corporation today,announced that its Investigational New ... endogenous insulin production capacity in new-onset,type 1 diabetes ... period,by the U.S. Food and Drug Administration (FDA). ... in 2008 while focusing the majority,of its development ...
Cached Biology Technology:WuXi PharmaTech Announces Second Quarter 2007 Results 2WuXi PharmaTech Announces Second Quarter 2007 Results 3WuXi PharmaTech Announces Second Quarter 2007 Results 4WuXi PharmaTech Announces Second Quarter 2007 Results 5WuXi PharmaTech Announces Second Quarter 2007 Results 6WuXi PharmaTech Announces Second Quarter 2007 Results 7WuXi PharmaTech Announces Second Quarter 2007 Results 8WuXi PharmaTech Announces Second Quarter 2007 Results 9WuXi PharmaTech Announces Second Quarter 2007 Results 10Alba Therapeutics Announces IND for Beta Cell Preservation in Type 1 Diabetes Using AT-1001 2
(Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
(Date:4/20/2015)... , April 20, 2015 The ... Glenbeigh Records Management (GRM), Ireland,s ... Dubai Islamic Bank. Having built up an impressive track record ... a leading player within the records management sector in ... to double is GCC staffbase and employ a further eight ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... rare species of forget-me-nots have been added to Flora ... mountains of the South Island during an expedition led by Dr. ... an article published in the open access journal PhytoKeys ... group of botanists at the Museum of New Zealand ...
... pioneering surgical blood salvage technology developed at the University ... major surgery is carried out by reducing blood loss ... health care sector after gaining the CE mark and ... in the world leading University of Kirikkale University Hospital ...
... international team led by New York University School of ... world, has completed the first genome-wide and single-nucleotide resolution ... and Harpegnathos saltator . It provides new ... differentiation of ants and also shed light on the ...
Cached Biology News:No ordinary forget-me-nots 2New technology to transform blood processing 2New technology to transform blood processing 3The first ant methylomes uncover the relationship between DNA methylation and caste differentiation 2The first ant methylomes uncover the relationship between DNA methylation and caste differentiation 3
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
... Mouse pan B (B220), 4.5 m, ... the efficient positive isolation or depletion ... spleen or lymph node cell suspensions. ... B cells and lytically active subsets ...
... agent and DNA-topoisomersae II inhibitor (IC50 = 59.2 ... C 29 H 32 O 13 ... Store at: RT ... Soluble to 100 mM ...
POU domain, class 2, transcription factor 2,...
Biology Products: